, Lancet, vol.390, pp.1685-99, 2017.
Review: defining a unified vascular phenotype in systemic sclerosis, Arthritis Rheumatol, vol.70, pp.162-70, 2018. ,
Mortality in systemic sclerosis: lessons learned from populationbased and observational cohort studies, Curr Opin Rheumatol, vol.26, pp.131-138, 2014. ,
Causes and risk factors for death in systemic sclerosis: a study from the eUlaR scleroderma Trials and Research (eUsTaR) database, Ann Rheum Dis, vol.69, pp.1809-1824, 2010. ,
Determinants of mortality in systemic sclerosis: a focused review, Rheumatol Int, vol.38, pp.1847-58, 2018. ,
Hand impairment in systemic sclerosis: various manifestations and currently available treatment, Curr Treatm Opt Rheumatol, vol.2, pp.252-69, 2016. ,
Validation of the aCR/eUlaR classification criteria for systemic sclerosis in patients with early scleroderma, Rheumatol Int, vol.37, pp.1825-1858, 2017. ,
Myeloablative autologous stem-cell transplantation for severe scleroderma, N Engl J Med, vol.378, pp.35-47, 2018. ,
systemic sclerosis: autologous HsCT is efficacious, but can we make it safer, Nat Rev Rheumatol, vol.14, pp.189-91, 2018. ,
Update of eUlaR recommendations for the treatment of systemic sclerosis, Ann Rheum Dis, vol.76, pp.1327-1366, 2017. ,
adipose-derived mesenchymal stem cells in autoimmune disorders: state of the art and perspectives for systemic sclerosis, Clin Rev Allergy Immunol, vol.52, pp.234-59, 2017. ,
Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis, J Autoimmun, vol.70, pp.31-40, 2016. ,
antifibrotic, antioxidant, and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis, Arthritis Rheumatol, vol.68, pp.1013-1038, 2016. ,
Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis, Cell Transplant, vol.22, pp.779-95, 2013. ,
adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation, Stem Cell Res Ther, vol.8, p.145, 2017. ,
The adipose stromal vascular fraction as a complex cellular source for tissue engineering applications, Tissue Eng Part B Rev, vol.24, pp.289-99, 2018. ,
Characterization of vasculogenic potential of human adipose-derived endothelial cells in a three-dimensional vascularized skin substitute, Pediatr Surg Int, vol.32, pp.17-27, 2016. ,
sphingosine kinase 1 expressed by endothelial colony-forming cells has a critical role in their revascularization activity, Cardiovasc Res, vol.103, pp.121-151, 2014. ,
, , 2019.
tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase i trial, Ann Rheum Dis, vol.74, pp.2175-82, 2015. ,
long-term follow-up after autologous adiposederived stromal vascular fraction injection into fingers in systemic sclerosis patients, Curr Res Transl Med, vol.65, pp.40-43, 2017. ,
stromal vascular fraction from adipose tissue forms profound vascular network through the dynamic reassembly of blood endothelial cells, Arterioscler Thromb Vasc Biol, vol.31, pp.1141-50, 2011. ,
new fat-derived products for treating skininduced lesions of scleroderma in nude mice, Stem Cell Res Ther, vol.5, p.138, 2014. ,
effects of the intramyocardial implantation of stromal vascular fraction in patients with chronic ischemic cardiomyopathy, J Transl Med, vol.14, p.158, 2016. ,
The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review, Autoimmun Rev, vol.16, pp.774-86, 2017. ,
Update on the pathogenesis of scleroderma: focus on circulating progenitor cells, F1000Res, vol.5, p.723, 2016. ,
expression of transforming growth factor ? receptor ii in mesenchymal stem cells from systemic sclerosis patients, BMJ Open, vol.3, p.1890, 2013. ,
scleroderma mesenchymal stem cells display a different phenotype from healthy controls; implications for regenerative medicine, Angiogenesis, vol.16, pp.595-607, 2013. ,
Phenotypical and functional characteristics of in vitro-expanded adipose-derived mesenchymal stromal cells from patients with systematic sclerosis, Cell Transplant, vol.26, pp.841-54, 2017. ,
endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis, Ann Rheum Dis, vol.76, pp.924-958, 2017. ,
insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells, Arthritis Rheum, vol.63, pp.3552-62, 2011. ,
shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis, Arthritis Res Ther, vol.7, pp.1113-1136, 2005. ,
Diabetes impairs adipose tissue-derived stem cell function and efficiency in promoting wound healing, Wound Repair Regen, vol.21, pp.545-53, 2013. ,
adipose-derived stromal vascular fraction cells isolated from old animals exhibit reduced capacity to support the formation of microvascular networks, Exp Gerontol, vol.63, pp.18-26, 2015. ,
35 awgulewitsch CP, Trinh lT, Hatzopoulos aK. The vascular wall: a plastic hub of activity in cardiovascular homeostasis and disease, Stem Cell Res Ther, vol.5, p.51, 2014. ,
The vascular adventitia: an endogenous, omnipresent source of stem cells in the body, Pharmacol Ther, vol.171, pp.13-29, 2017. ,
Merfeld-Clauss s, et al. Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells, Circ Res, vol.104, pp.1410-1430, 2009. ,
a population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks, Circ Res, vol.102, pp.77-85, 2008. ,
Vascular stem/progenitor cells: functions and signaling pathways, Cell Mol Life Sci, vol.75, pp.859-69, 2018. ,
serum apelin levels in systemic sclerosis, J Eur Acad Dermatol Venereol, vol.27, p.1586, 2013. ,
serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis, J Eur Acad Dermatol Venereol, vol.27, pp.37-42, 2013. ,
single Cell Rna sequencing identifies HsPG2 and aPlnR as markers of endothelial cell injury in systemic sclerosis skin, Front Immunol, vol.9, p.2191, 2018. ,
abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases, Cell Mol Life Sci, vol.74, pp.2899-916, 2017. ,
The role of B7 family costimulatory molecules and indoleamine 2,3-dioxygenase in primary sjögren's syndrome and systemic sclerosis, Immunol Res, vol.65, pp.622-631, 2017. ,
Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development, Arthritis Rheumatol, vol.66, pp.418-445, 2014. ,
Growth Differentiation Factor-15 (GDF-15) level and relation to clinical manifestations in egyptian systemic sclerosis patients: preliminary data, Immunol Invest, vol.46, pp.703-716, 2017. ,
Clinical significance of serum growth differentiation factor-15 levels in systemic sclerosis: association with disease severity, Mod Rheumatol, vol.22, pp.668-75, 2012. ,
serum amyloid a is a marker for pulmonary involvement in systemic sclerosis, PLoS One, vol.10, p.110820, 2015. ,
Regulation of inflammation and angiogenesis in giant cell arteritis by acute-phase serum amyloid a, Arthritis Rheumatol, vol.67, pp.2447-56, 2015. ,
Deficiency of hyaluronan synthase 1 (Has1) results in chronic joint inflammation and widespread intra-articular fibrosis in a murine model of knee joint cartilage damage, Osteoarthritis Cartilage, vol.23, pp.1879-89, 2015. ,
, , 2019.